Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01364779 · ClinicalTrials.gov registry record

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
15
Enrollment target

NCT01364779 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01364779 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
15 participants
Enrollment target

Study Summary

The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2010-04
Est. Completion 2012-03

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT01364779

The ClinicalTrials.gov registry entry for NCT01364779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01364779 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01364779 about?

NCT01364779 is a clinical study titled "Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients". The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

What is the current status of trial NCT01364779?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2010-04. Estimated completion is 2012-03.

Who is sponsoring clinical trial NCT01364779?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.